Camille Adeimy is an Oncology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 12 publications with 608 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1100 San Bernardino Rd
Suite 1100
Upland, CA 917864952
Telephone
909-949-2242Provider last certified this registry record 23 Mar 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20232 payments
- Alexion Pharmaceuticals, Inc.Program year20211 payment
- AstraZeneca Pharmaceuticals LPProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
57%Aromatase Inhibitor19.1%Anastrozole100%Part D≥28 patientsCytochrome P450 17A1 Inhibitor10.6%Abiraterone Acetate100%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
25.5%Serotonin-3 Receptor Antagonist15.8%Ondansetron Odt60%Ondansetron Hcl40%Part D≥27 patientsCorticosteroid9.7%Prednisone100%Part D≥15 patientsSensory organs
10.4%Corticosteroid10.4%Dexamethasone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Leveraging an Informatics Approach to Identify an Unmet Clinical Need for <i>BRCA1</i>/<i>2</i> Testing Among Patients With Ovarian Cancer
JCO Clinical Cancer Informatics
2022 - New frontiers in the treatment of cholangiocarcinoma: a narrative review
Digestive Medicine Research
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Erminia Massarelli, MD
City Of Hope National Medical Center
Swetha Thiruvengadam, MD
City Of Hope National Medical Center
Yuman Fong, MD
City Of Hope National Medical Center
Ravi Salgia, MD, PhD
City Of Hope National Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”